Author: News Room

BRISBANE, Calif., Jan. 08, 2024 (GLOBE NEWSWIRE) — Vera Therapeutics, Inc. (Nasdaq: VERA), a late clinical-stage biotechnology company developing and commercializing transformative treatments for patients with serious immunologic diseases, today announced the appointments of two industry veterans to help lead the development of the company’s drug programs including its late-stage product candidate, atacicept, to treat autoimmune diseases, currently in a Phase 3 clinical trial for IgA nephropathy (IgAN). The company has appointed Robert M. Brenner, M.D., as Chief Medical Officer to succeed Dr. Celia Lin, M.D.; and William D. Turner as Chief Development Officer, effective immediately. “We are excited to…

Dublin, Jan. 08, 2024 (GLOBE NEWSWIRE) — The “Handbag Market Size, Share & Trends Analysis Report By Raw Material (Leather, Fabric), By Product (Tote Bag, Clutch), By Distribution Channel, By Region, And Segment Forecasts, 2023 – 2030” report has been added to ResearchAndMarkets.com’s offering.The global handbag market size is estimated to reach USD 124.10 billion by 2030 and is anticipated to grow at a CAGR of 6.8% from 2023 to 2030 The market is primarily driven by a combination of factors that cater to both functional and fashion-conscious consumers. First and foremost, fashion trends and brand influence play a significant…

MONTRÉAL, Jan. 08, 2024 (GLOBE NEWSWIRE) — NioBay Metals inc. (“NioBay” or the “Company”) (TSX-V: NBY) (OTCQB: NBYCF) is pleased to announce the first results of the Fall 2023 drilling program at its 72.5%-owned Crevier niobium & tantalum project (the “Crevier Project”). The Crevier Project is located about 50 km north of the town of Girardville and about 150 km from the Niobec mine. It is located on the Nitassinan (or ancestral territory) of the Pekuakamiulnuatsh, whose main population centre is Mashteuiatsh. This property is easily accessible via existing logging roads. Update on the results of the 2023 drilling program…

Dublin, Jan. 08, 2024 (GLOBE NEWSWIRE) — The “Stoma/Ostomy Care – Global Strategic Business Report” report has been added to ResearchAndMarkets.com’s offering.Global Stoma/Ostomy Care Products Market to Reach $5.1 Billion by 2030The global market for Stoma/Ostomy Care Products estimated at US$3.3 Billion in the year 2022, is projected to reach a revised size of US$5.1 Billion by 2030, growing at a CAGR of 5.5% over the analysis period 2022-2030. The report begins with an introduction to the subject, highlighting global Ostomy Prevalence in 2020 by the type of stoma, with a specific focus on prevalence among different age groups and…

Dublin, Jan. 08, 2024 (GLOBE NEWSWIRE) — The “Global Clinical Trial Supplies Market by Services (Manufacturing, Packaging, Logistics), Phases, Type (Small Molecules, Biologics), Therapeutic Areas (Oncology, CVD, Infectious, Immunology), End User (Pharma, Biotech, CROs), & Region – Forecast to 2028” report has been added to ResearchAndMarkets.com’s offering. The global clinical trial supplies market is projected to reach USD 6.3 billion by 2028 from USD 3.9 billion in 2023, at a CAGR of 9.9% The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall clinical trial supplies market and its…

Dublin, Jan. 08, 2024 (GLOBE NEWSWIRE) — The “Global Sustainable Aviation Fuel Market by Fuel Type (Biofuel, Hydrogen Fuel Cell, Power to Liquid, Gas to Liquid), Biofuel Manufacturing Technology, Blending Capacity (Below 30%, 30% to 50%, Above 50%), Platform and Region – Forecast to 2030” report has been added to ResearchAndMarkets.com’s offering. The global sustainable aviation fuel market is expected to grow from USD 1.1 billion in 2023 at a CAGR of 47.7% during the forecast period, reaching USD 16.8 billion by 2030 The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges,…

Highlights Company has received final assays from Phase II of its two-phase 2023 soil-sampling programPhase II Program extends two multi-element (Cu-Ag-Au-Te) anomalies with coincident chargeability highs identified along Trojan-Condor Corridor in Phase I (Figure 1)Multi-element ore and pathfinder element soil geochemical anomalies at 10 additional target areas, including strong porphyry-style Cu-Mo-Au anomalies at Lamont Ridge and Coalmont Road targets VANCOUVER, British Columbia, Jan. 08, 2024 (GLOBE NEWSWIRE) — COLLECTIVE METALS INC. (CSE: COMT | OTC: CLLMF | FSE: TO1) (the “Company” or “Collective”) is pleased to announce it has received final assay results for soil samples collected from Phase II of the…

Dublin, Jan. 08, 2024 (GLOBE NEWSWIRE) — The “Global Edible Offal Market Size, Share & Industry Trends Analysis Report By Application, By Distribution Channel, By Source (Pig, Goat, Sheep, Cattle, Poultry, Horse and Others), By Regional Outlook and Forecast, 2023 – 2030” report has been added to ResearchAndMarkets.com’s offering.The Global Edible Offal Market size is expected to reach $58.2 billion by 2030, rising at a market growth of 4.7% CAGR during the forecast period. In the year 2022, the market attained a volume of 13,319.2 Kilo Tonnes, experiencing a growth of 2.3% (2019-2022).Young people and millennials, as savvy consumer groups,…

Dublin, Jan. 08, 2024 (GLOBE NEWSWIRE) — The “Global Digital Printing for Tableware Market by Application (Ceramic & Porcelain, Glass, Plastic, Bone China, Earthenware, Stoneware), Ink type (Ceramic ink, UV ink, Solvent-based ink) and Region – Forecast to 2029” report has been added to ResearchAndMarkets.com’s offering. The global Digital Printing for Tableware market is projected to reach USD 452 million by 2029 from USD 326 million in 2024; it is expected to grow at a CAGR of 6.8% from 2024 to 2029. The convergence of technological advancements and increasing consumer demand for personalized and unique tableware products is fueling this…

Pluri, an established global leader in the development and manufacturing of cell-based therapeutics, launches new revenue-generating Contract Development and Manufacturing Organization (CDMO) division.PluriCDMO™ will help innovative companies develop and manufacture life-changing therapies within the rapidly growing $5.2 billion cell and gene therapy sector.PluriCDMO™ includes Pluri’s well-established team as well as a Good Manufacturing Practice (GMP) facility and a state-of-the-art, proprietary bioreactor system enabling 3D cell expansion and supporting the manufacture of stem cells, Induced Pluripotent Stem Cells, Exosomes and Immuno therapeutics.PluriCDMO™ will offer manufacturing support from the preclinical and development stages to late stage clinical and commercial production, including fill…